Statistics

Total Visits

Views
Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)65

Select a period of time:

Number of views in the range

Views
Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)49

Views

Views
February 20257
March 202515
April 20252
May 20251
June 20251
July 202521
August 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States13
Brazil9
Spain6
Venezuela2
Egypt2
Germany1
Hong Kong1
 

Top cities views

Views
Narón5
Giza2
Belém1
Bragança Paulista1
Carlinville1
Chicago1
Council Bluffs1
Cúa1
Hong Kong1
Imperatriz1